BioSpace News Archive

Genetown

Stoke Therapeutics to Present at the BofA Securities Health Care Conference

Stoke Therapeutics, Inc. today announced that management will present at the BofA Securities Health Care Conference on Thursday, May 11, 2023, at 11:00 a.m. ET. (8:00 a.m. PT).

May 3, 2023
·
1 min read
BioMidwest

Gate Neurosciences Hones in on Precision Medicine with Expanded Research Operations Supporting Its Synaptic Function-Enhancing Molecules

Gate Neurosciences announced it has increased its R&D capabilities with new expanded research operations and lab facilities in Evanston, Illinois.

May 3, 2023
·
4 min read
Genetown

Apertura Gene Therapy Announces Scientific Founder Presentations on AAV Capsid Engineering Platforms at ASGCT 2023 Annual Meeting

Apertura Gene Therapy today announced that academic collaborator and scientific co-founder, Ben Deverman, PhD, Senior Director of Vector Engineering and Institute Scientist at the Broad Institute of MIT and Harvard, will present at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).

May 3, 2023
·
4 min read
Business

EvoEndo Elects David Pierce to the Board of Directors

EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), is proud to announce that David Pierce has joined our Board of Directors.

May 3, 2023
·
1 min read
Genetown

SeQure Dx to present at American Society of Gene and Cell Therapy (ASGCT) on the importance of incorporating population heterogeneity evaluation into gene editing and cell therapy off-target analyses

SeQure Dx, Inc announced today it will present new data at the 2023 American Society of Gene and Cell Therapy Annual Meeting from May 16 - 20 in Los Angeles.

May 3, 2023
·
2 min read
Business

Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer

Pulse Biosciences, Inc. today announced the appointment of Gansevoort “Gan” Dunnington, M.D. as its Chief Medical Officer.

May 3, 2023
·
4 min read
Business

Forge Biologics and Labcorp Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration

Forge Biologics, a leading manufacturer of genetic medicines, today announced a gene therapy development and manufacturing collaboration with Labcorp (NYSE: LH), a leading global life sciences company.

May 3, 2023
·
3 min read
Biotech Bay

Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference

Pasithea Therapeutics Corp. today announced its CEO, Tiago Reis Marques, and its VP of Business Development, Mathew Lazarus will participate in the EF Hutton Global Conference, held in New York City, May 10-11.

May 3, 2023
·
2 min read
Biotech Bay

Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts

The recent national conversation on hepatitis C (HCV) is an encouraging step towards viral hepatitis elimination in the U.S. With its long history of leadership in viral hepatitis, Gilead continues to support efforts that focus on HCV elimination.

May 3, 2023
·
3 min read
Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

Femasys Inc. (NASDAQ: FEMY) today announced that Health Canada, the Public Health Agency of Canada, has granted product approval of FemCerv®, the first endocervical tissue sampler (curette) designed to collect and contain a comprehensive sample to maximize quality and quantity.

May 3, 2023
·
4 min read